Related Experiment Video
Updated: Nov 9, 2025
08:42
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
4.7K
SLPI is a critical mediator that controls PTH-induced bone formation
Akito Morimoto1,2, Junichi Kikuta3,4,5, Keizo Nishikawa1,2
1Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Osaka, Japan.
Nature Communications
|April 10, 2021
Summary
Secretory leukocyte protease inhibitor (SLPI) is crucial for parathyroid hormone (PTH) to promote bone formation. SLPI enhances osteoblast function and communication with osteoclasts, aiding in osteoporosis treatment.
Area of Science:
- Bone Biology
- Endocrinology
- Cellular Metabolism
Background:
- Bone metabolism involves a balance between osteoclastic bone resorption and osteoblastic bone formation.
- Parathyroid hormone (PTH) is an anabolic agent used in osteoporosis treatment, shifting this balance towards bone formation.
- The precise mechanisms of PTH-mediated cellular coordination in bone remodeling remain incompletely understood.
Purpose of the Study:
- To identify key mediators involved in the parathyroid hormone (PTH)-induced shift in bone metabolism towards anabolism.
- To investigate the role of secretory leukocyte protease inhibitor (SLPI) in PTH-mediated bone remodeling.
- To elucidate how SLPI regulates communication between osteoblasts and osteoclasts.
Main Methods:
- Investigated the role of SLPI in PTH-mediated bone formation using genetic ablation models.
- Quantified SLPI expression in osteoblasts following PTH stimulation.
- Assessed osteoblast differentiation and osteoblast-osteoclast interactions.
- Utilized intravital bone imaging to observe cell-cell interactions in vivo.
Main Results:
- Parathyroid hormone (PTH) significantly upregulates secretory leukocyte protease inhibitor (SLPI) in osteoblasts.
- Genetic deletion of SLPI markedly impairs PTH-induced bone formation.
- SLPI enhances osteoblast differentiation and promotes osteoblast-osteoclast contact, suppressing osteoclast activity.
- Absence of SLPI disrupts PTH-dependent osteoblast-osteoclast associations.
Conclusions:
- Secretory leukocyte protease inhibitor (SLPI) is a critical mediator of PTH's anabolic effects on bone.
- SLPI regulates inter-cellular communication between osteoblasts and osteoclasts.
- Targeting SLPI may offer a novel therapeutic strategy for enhancing bone anabolism in conditions like osteoporosis.
More Related Videos
11:20Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
Published on: March 29, 2018
7.8K
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
3.6K
Related Concept Videos
01:17Hormones and Bone Tissue
3.3K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.3K
01:40Bone Remodeling
39.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
39.3K
01:31Osteoclasts in Bone Remodeling
3.5K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.5K
01:27Roles of Electrolytes: Calcium and Phosphate
826
Calcium and phosphate are essential electrolytes in the human body, with calcium being the most abundant mineral. Around 99% of the body's calcium is stored in the skeleton and teeth, forming a crystal lattice of mineral salts in combination with phosphates. Calcium plays crucial roles in various bodily functions such as blood clotting, neurotransmitter release, muscle tone maintenance, and nervous and muscle tissue excitability.
The calcium concentration in blood plasma is primarily...
The calcium concentration in blood plasma is primarily...
826
01:20The JAK-STAT Signaling Pathway
10.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
10.0K
01:21Skeleton and Calcium Homeostasis
5.3K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
5.3K